A retrospective cohort study to determine effectiveness and safety outcomes of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Stroke; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 09 Nov 2021 New trial record